These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3912191)

  • 1. The phagocytosis of yeast cells by blood monocytes. Effects of therapeutic concentrations of Vinca alkaloids.
    Athlin L; Domellöf L; Norberg B
    Eur J Clin Pharmacol; 1985; 29(4):471-6. PubMed ID: 3912191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z; Ochs S
    J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of tissue concentrations of vinca alkaloids by radioimmunoassay.
    Owellen RJ; Blair M; Van Tosh A; Hains FC
    Cancer Treat Rep; 1981; 65(5-6):469-75. PubMed ID: 7237468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.
    Owellen RJ; Hartke CA; Dickerson RM; Hains FO
    Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer.
    Zhang Y; Yang SH; Guo XL
    Biomed Pharmacother; 2017 Dec; 96():659-666. PubMed ID: 29035832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adherence of polymorphonuclear leucocytes to an albumin-coated glass surface. Effects of therapeutic concentrations of the Catharantus derivatives vincristine, vinblastine and vindesine.
    Dahlgren C; Norberg B; Eriksson S
    Acta Med Scand; 1987; 221(1):109-13. PubMed ID: 3565080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
    Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR
    Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
    Dorr RT; Alberts DS
    J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of axoplasmic transport in vitro by vinca alkaloids.
    Chan SY; Worth R; Ochs S
    J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells.
    Van Belle SJ; De Smet MC; De Mey JE; Storme GA
    Anticancer Res; 1991; 11(1):465-71. PubMed ID: 2018383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence and phagocytosis of yeast cells by blood monocytes. Effects in vitro of a therapeutic doxycycline concentration.
    Athlin L; Domellöf L; Norberg B
    Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):227-30. PubMed ID: 6391087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment.
    Al-Ahmad A; Kümmerer K
    Cancer Detect Prev; 2001; 25(1):102-7. PubMed ID: 11270417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Vinca alkaloid acceptors in P388 murine leukemia cells with a photoactive analogue of vinblastine.
    Safa AR; Glover CJ; Felsted RL
    Cancer Res; 1987 Oct; 47(19):5149-54. PubMed ID: 3621200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to antitumor Vinca alkaloids: thermodynamics and kinetics.
    Pontarotti PA; Rahmani R; Martin M; Barbet J
    Mol Immunol; 1985 Mar; 22(3):277-84. PubMed ID: 4000131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phagocytosis of yeast cells by monocytes: effects of colchicine, beta-lumicolchicine, and gamma-lumicolchicine.
    Athlin L; Domellof L; Norberg BO
    Lymphology; 1986 Sep; 19(3):130-5. PubMed ID: 3537551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of vindesine and vincristine in humans.
    Owellen RJ; Root MA; Hains FO
    Cancer Res; 1977 Aug; 37(8 Pt 1):2603-7. PubMed ID: 872088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic concentrations of griseofulvin do not affect yeast cell phagocytosis by monocytes.
    Athlin L; Domellöf L; Norberg B
    Dermatologica; 1987; 174(3):122-7. PubMed ID: 3549384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension.
    Zhou XJ; Placidi M; Rahmani R
    Anticancer Res; 1994; 14(3A):1017-22. PubMed ID: 8074443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets.
    Ahn YS; Byrnes JJ; Harrington WJ; Cayer ML; Smith DS; Brunskill DE; Pall LM
    N Engl J Med; 1978 May; 298(20):1101-7. PubMed ID: 565464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
    Poppitt DG; McGown AT; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.